Journals / Retina-Vitreus / 2014 / Cilt: 22 - Sayı: 3

A new staging system for eales' disease based on the clinicopathological correlation

Pages
194–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The new classification system based on clinicopathological correlation is both user friendly and convenient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the clinical features and propose a new staging system based on the clinicopathological correlation and formulate new guidelines for management of Eales’ disease in healthy young males.
📊
Key Findings & Data:Materials and Methods: From 2004 to 2010, patients clinically diagnosed with Eales’ disease were enrolled in this study using specific inclusion and exclusion criteria.
💡
Conclusion & Impact:Conclusion: The new classification system based on clinicopathological correlation is both user friendly and convenient.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate the clinical features and propose a new staging system based on the clinicopathological correlation and formulate new guidelines for management of Eales’ disease in healthy young males. Materials and Methods: From 2004 to 2010, patients clinically diagnosed with Eales’ disease were enrolled in this study using specific inclusion and exclusion criteria. We examined the patients’ anterior and posterior segments thoroughly. We performed the necessary ocular and systemic investigations. We divided the investigations into three stages: inflammatory, ischemic and complications, and the patients were treated accordingly. We treated the patients using photocoagulation or pars plana vitrectomy. The patients were monitored according to standard schedules and formats. All information was documented using a pre-tested online format and statistical analyses were performed using SPSS ver. 17. A p-value<0.05 was considered to indicate significance. Results: The cohort comprised 74 cases with a mean age of 30±8.73 years. The visual acuity of the presenting cohort was <3/60 in 64.9% of eyes. The final visual outcome was >6/12 in 40 eyes (54.1%), 6/60 to 6/18 in 14 eyes (18.9%) and <1/60 in the remaining 9 eyes at a mean follow-up of 592 days. The visual parameters differed significantly pre- and post-treatment. We evaluated the visual outcome following surgical management. Conclusion: The new classification system based on clinicopathological correlation is both user friendly and convenient.

🔖

Cite This Article

SHAH, M., SHAH, S., UPADHYAY, P., MEHTA, R. (2014). A new staging system for eales' disease based on the clinicopathological correlation. Retina-Vitreus, Cilt: 22 - Sayı: 3, 194–198. https://ajindex.com/articles/308139

References (18)

  1. Eales’ H. Cases of retinal hemorrhage associated with epistaxis and constipation. Birmingham Medical Review 1880
  2. Eales H. Primary retinal hemorrhage in young men. Ophthalmic Rev 1882
  3. Elliot AJ. 30-year observation of patient with Eales’ disease. Am J Ophthalmol 1975
  4. Wardsworth. Recurrent retinal hemorrhage followed by the development of blood vessels in the vitreous. Ophthalmic Rev 1887
  5. 289 5. Das T, Biswas J, Kumar A, et al. Eales’ disease. Indian J Oph- thalmol 1994
  6. Duke-Elder S, Dobree JH. System of Ophthalmology Vol X. Lon- don: Henry Kimpton. 7. Biswas J, Sharma T, Gopal L, et al. Eales’ disease: an update. Surv Ophthalmol 2002
  7. Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epireti- nal membranes in Eales’ disease. Invest Ophthalmol Vis Sci 2000
  8. Biswas J, Rao NA. Epiretinal membrane in Eales’ disease and other vascular retinopathies. Invest Ophllmlmol Vis Sci 1990
  9. Badrinath SS, Biswas J, Sharma T, Rao N. Immunophenotyping of inflammatory infiltrates in epiretinal (ERM) and sub retinal membrane (SRM) in Eales’ disease. Invest Ophthalmol Vis Sci 1992
  10. Das T, Namperumalsamy P. Combined photocoagulation and cryotherapy in treatment of Eales’ retinopathy. Proc All Ind Ophthalmol Soc 1987
  11. Saxena S, Kumar D. Safety of oral methotrexate pulsed therapy. Indian J Ophthalmol 2000
  12. Pathengay A, Pilli S, Das T. Intravitreal triamcinolone aceton- ide in Eales’ disease: a case report. Eye 2005
  13. Chanana B, Azad RV, Patwardhan S. Role of intravitreal bevaci- zumab in the management of Eales’ disease. Int Ophthalmol 2009. 15. Saxena, S. and D. Kumar.New classification system-based visual outcome in Eales’ disease. Indian J Ophthalmol 2007
  14. Davis, J., S. H. Schecter, et al. Eales’ disease: the great masquer- ader. Optometry 2009
  15. Shrestha, J. K., D. Khadka, et al. Retinal vasculitis. Nepal J Ophthalmol 2009
  16. Stoffelns, B. M., C. Kramann, et al.Eales’ disease-10 years experience with a rare disease. Klin Monbl Augenheilkd 2009
  17. Badrinath SS, Gopal L, Sharma T, et al. Vitreoschisis in Eales disease: pathogenic role and significance in surgery. Retina 1999
  18. Badrinath SS, Gopal L, Sharma T, et al. Morphological descrip- tion Of surgical anatomy of Eales disease-A pilot study. Presented at 100 th annual mee